Plasma carotenoids and recurrence-free survival in women with a history of breast cancer
- PMID: 16170170
- DOI: 10.1200/JCO.2005.19.505
Plasma carotenoids and recurrence-free survival in women with a history of breast cancer
Abstract
Purpose: Previous studies suggest that diet may affect recurrence or survival rates in women who have been diagnosed with breast cancer. The purpose of this study was to examine the relationship between plasma carotenoid concentration, as a biomarker of vegetable and fruit intake, and risk for a new breast cancer event in a cohort of women with a history of early-stage breast cancer.
Methods: Participants were 1,551 women previously treated for breast cancer who were randomly assigned to the control arm of a diet intervention trial between March 1995 and November 2000. Outcome events were probed during semiannual interviews and verified by medical record review. During the period under study, 205 women had a recurrence or new primary breast cancer. Plasma carotenoid concentrations were measured in baseline blood samples. Hazard ratios (HR) and 95% CIs by quartiles of plasma carotenoids were computed, controlling for tumor stage, grade, and hormone receptor status; chemotherapy and tamoxifen therapy; clinical site; age at diagnosis; body mass index; and plasma cholesterol concentration.
Results: Women in the highest quartile of plasma total carotenoid concentration had significantly reduced risk for a new breast cancer event (HR, 0.57; 95% CI, 0.37 to 0.89), controlled for covariates influencing breast cancer prognosis.
Conclusion: Plasma carotenoids are a biologic marker of intake of vegetables and fruit, so this observation supports findings from previous studies that have linked increased vegetable and fruit intake with greater likelihood of recurrence-free survival in women who have been diagnosed with early-stage breast cancer.
Similar articles
-
Responsiveness of carotenoids to a high vegetable diet intervention designed to prevent breast cancer recurrence.Cancer Epidemiol Biomarkers Prev. 1997 Aug;6(8):617-23. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9264275 Clinical Trial.
-
Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study.Breast Cancer Res Treat. 2005 Nov;94(2):135-44. doi: 10.1007/s10549-005-6654-9. Breast Cancer Res Treat. 2005. PMID: 16261412
-
Reduction in fat intake is not associated with weight loss in most women after breast cancer diagnosis: evidence from a randomized controlled trial.Cancer. 2001 Jan 1;91(1):25-34. Cancer. 2001. PMID: 11148556 Clinical Trial.
-
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9. Breast Cancer Res Treat. 2008. PMID: 17687650 Review.
-
Dietary patterns, risk and prognosis of breast cancer.Future Oncol. 2009 Oct;5(8):1257-69. doi: 10.2217/fon.09.86. Future Oncol. 2009. PMID: 19852740 Review.
Cited by
-
Dietary modifications, weight loss, and changes in metabolic markers affect global DNA methylation in Hispanic, African American, and Afro-Caribbean breast cancer survivors.J Nutr. 2015 Apr;145(4):783-90. doi: 10.3945/jn.114.202853. Epub 2015 Feb 4. J Nutr. 2015. PMID: 25833781 Free PMC article. Clinical Trial.
-
Integrative Approaches to the Treatment of Cancer.Cancers (Basel). 2022 Nov 30;14(23):5933. doi: 10.3390/cancers14235933. Cancers (Basel). 2022. PMID: 36497414 Free PMC article. Review.
-
Lycopene for the prevention of prostate cancer.Cochrane Database Syst Rev. 2011 Nov 9;2011(11):CD008007. doi: 10.1002/14651858.CD008007.pub2. Cochrane Database Syst Rev. 2011. PMID: 22071840 Free PMC article.
-
Plasma carotenoids and risk of breast cancer over 20 y of follow-up.Am J Clin Nutr. 2015 Jun;101(6):1197-205. doi: 10.3945/ajcn.114.105080. Epub 2015 Apr 15. Am J Clin Nutr. 2015. PMID: 25877493 Free PMC article.
-
Halophilic Carotenoids and Breast Cancer: From Salt Marshes to Biomedicine.Mar Drugs. 2021 Oct 21;19(11):594. doi: 10.3390/md19110594. Mar Drugs. 2021. PMID: 34822465 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical